Helicobacter pylori and peptic ulcer disease

Recent developments

Robert Kozol

Research output: Contribution to journalArticle

Abstract

In this day and age, it is rare to discover a medical breakthrough which defies decades of medical dogma. The concept of bacterial infection causing peptic ulcer represents such an event. After an explosion of scientific research during the 1980s, the 'ulcer causing bacteria' made it to popular news-stand magazines during the 1990s. Over this time span, Helicobacter pylori underwent two name changes, from Campylobacter pyloridis to Campylobacter pylori to its current moniker. This review covers our current understanding of the pathophysiology, diagnosis and treatment of Helicobacter pylori-associated gastroduodenal inflammatory states.

Original languageEnglish
Pages (from-to)145-149
Number of pages5
JournalExpert Opinion on Investigational Drugs
Volume5
Issue number2
StatePublished - Jan 1 1996

Fingerprint

Peptic Ulcer
Helicobacter pylori
Campylobacter
Explosions
Bacterial Infections
Ulcer
Names
Bacteria
Research

ASJC Scopus subject areas

  • Pharmacology

Cite this

Helicobacter pylori and peptic ulcer disease : Recent developments. / Kozol, Robert.

In: Expert Opinion on Investigational Drugs, Vol. 5, No. 2, 01.01.1996, p. 145-149.

Research output: Contribution to journalArticle

@article{1931a1877c5847d19c9d15debd01064d,
title = "Helicobacter pylori and peptic ulcer disease: Recent developments",
abstract = "In this day and age, it is rare to discover a medical breakthrough which defies decades of medical dogma. The concept of bacterial infection causing peptic ulcer represents such an event. After an explosion of scientific research during the 1980s, the 'ulcer causing bacteria' made it to popular news-stand magazines during the 1990s. Over this time span, Helicobacter pylori underwent two name changes, from Campylobacter pyloridis to Campylobacter pylori to its current moniker. This review covers our current understanding of the pathophysiology, diagnosis and treatment of Helicobacter pylori-associated gastroduodenal inflammatory states.",
author = "Robert Kozol",
year = "1996",
month = "1",
day = "1",
language = "English",
volume = "5",
pages = "145--149",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Helicobacter pylori and peptic ulcer disease

T2 - Recent developments

AU - Kozol, Robert

PY - 1996/1/1

Y1 - 1996/1/1

N2 - In this day and age, it is rare to discover a medical breakthrough which defies decades of medical dogma. The concept of bacterial infection causing peptic ulcer represents such an event. After an explosion of scientific research during the 1980s, the 'ulcer causing bacteria' made it to popular news-stand magazines during the 1990s. Over this time span, Helicobacter pylori underwent two name changes, from Campylobacter pyloridis to Campylobacter pylori to its current moniker. This review covers our current understanding of the pathophysiology, diagnosis and treatment of Helicobacter pylori-associated gastroduodenal inflammatory states.

AB - In this day and age, it is rare to discover a medical breakthrough which defies decades of medical dogma. The concept of bacterial infection causing peptic ulcer represents such an event. After an explosion of scientific research during the 1980s, the 'ulcer causing bacteria' made it to popular news-stand magazines during the 1990s. Over this time span, Helicobacter pylori underwent two name changes, from Campylobacter pyloridis to Campylobacter pylori to its current moniker. This review covers our current understanding of the pathophysiology, diagnosis and treatment of Helicobacter pylori-associated gastroduodenal inflammatory states.

UR - http://www.scopus.com/inward/record.url?scp=0030019983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030019983&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 145

EP - 149

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 2

ER -